Question 1

How many shares of KNTE does RA CAPITAL MANAGEMENT, L.P. own?

Accepted Answer

RA CAPITAL MANAGEMENT, L.P. previously held 0 shares of KNTE (KINNATE BIOPHARMA INC) before exiting the position in 2023-Q2.

Question 2

What is RA CAPITAL MANAGEMENT, L.P.'s KNTE position worth?

Accepted Answer

RA CAPITAL MANAGEMENT, L.P.'s KNTE position was last reported at $0 in 2023-Q2 before the exit.

Question 3

Is RA CAPITAL MANAGEMENT, L.P. buying or selling KNTE?

Accepted Answer

In 2023-Q2, RA CAPITAL MANAGEMENT, L.P. exited their KNTE position entirely (-100.0% change in shares).

Question 4

When did RA CAPITAL MANAGEMENT, L.P. first buy KNTE?

Accepted Answer

Based on available 13F filings, RA CAPITAL MANAGEMENT, L.P. first reported a position in KNTE in 2020-Q4. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q1	Unchanged	4.3M	0.0%	$26.7M	0.6%	—	0
2022-Q4	Unchanged	4.3M	0.0%	$26M	0.5%	—	0
2022-Q3	Unchanged	4.3M	0.0%	$51M	1.1%	—	0
2022-Q2	Unchanged	4.3M	0.0%	$53.8M	1.4%	—	0
2022-Q1	Increased	4.3M	+18.7%	$48M	1.0%	—	54
2021-Q4	Unchanged	3.6M	0.0%	$63.7M	1.1%	—	0
2021-Q3	Unchanged	3.6M	0.0%	$82.7M	1.1%	—	0
2021-Q2	Unchanged	3.6M	0.0%	$83.6M	1.3%	—	0
2021-Q1	Unchanged	3.6M	0.0%	$112M	1.7%	—	0
2020-Q4	New	3.6M	-	$142.9M	2.0%	—	69

KNTE11 quarters

KNTE
11 quarters